TAIKO PHARMACEUTICAL CO., LTD. (4574) Balance sheet

Market cap

¥15.4B

P/E ratio

27.8x

Makes over-the-counter medicines like Seirogan and Cleverin infection control products, serving consumers and institutions across Japan and Asia.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	6,119	2,997	6,803	6,548	7,225	9,906	4,945	5,796	3,105	5,484	4,532	4,256
Marketable securities, current	-	-	-	-	-	-	-	-	302	400	-	-	-
Accounts receivable, net	-	1,863	2,196	1,821	3,385	3,646	4,419	7,919	4,056	1,798	1,985	2,428	-
Inventories	-	1,328	888	694	834	879	1,346	5,409	2,010	696	421	452	309
Total current assets	-	10,478	7,433	10,276	11,764	12,572	16,584	19,822	13,783	7,556	9,109	8,761	8,433
Property, plant and equipment, net	-	7,628	8,410	8,076	7,895	7,371	7,108	9,447	7,113	6,397	3,581	3,271	3,312
Marketable securities, non-current	-	-	-	21	332	741	735	1,231	1,011	533	236	461	-
Total non-current assets	-	8,121	8,875	8,513	8,709	9,028	8,890	11,936	8,751	7,489	4,111	4,152	3,837
Total assets	-	18,599	16,307	18,789	20,473	21,600	25,474	31,758	22,535	15,046	13,220	12,914	12,270
Accounts payable	-	350	239	302	424	514	1,006	2,929	309	274	375	338	-
Long-term debt, current	-	-	-	-	-	-	-	-	923	1,039	1,206	1,206	792
Total current liabilities	-	5,004	2,008	2,237	2,816	2,826	4,794	7,488	4,320	2,793	3,046	2,855	2,509
Total non-current liabilities	-	1,122	1,160	1,167	1,237	1,288	1,305	1,489	5,407	4,208	3,433	2,094	1,242
Total liabilities	-	6,126	3,168	3,404	4,053	4,115	6,100	8,976	9,728	7,001	6,480	4,949	3,752
Retained earnings	-	12,476	12,996	13,850	14,663	15,579	17,533	20,509	10,134	5,239	1,628	2,526	3,450
Stockholders' equity	11,406	12,473	13,140	15,385	16,420	17,485	19,374	22,781	12,807	8,044	6,739	7,964	8,518
Working capital	-												-